Center for Protein Research (CPR) Novo Nordisk Foundation Center for Protein Research was established in 2007 at the Faculty of Health and Medical Sciences, University of Copenhagen, to promote basic and applied discovery research on human proteins of medical relevance.
Dementias Platform UK (DPUK) DPUK is a world-leading resource for person-focused dementias research designed to fast-track scientific understanding, treatments and the prevention of the disease.
EU AD and RWE related Projects
European Prevention of Alzheimer's Dementia Consortium (EPAD) The EPAD project is part of a global effort in the fight against Alzheimer’s disease and is a major European initiative to create a novel environment for testing numerous interventions targeted at the prevention of Alzheimer’s dementia.
GetReal GetReal aims to show how robust new methods of RWE collection and synthesis could be adopted earlier in pharmaceutical R&D and the healthcare decision making process.
European Medical Information Framework (EMIF) The EMIF project aims to increase access to human health data improving life sciences research and bringing better and safer medicines to patients.
Amyloid imaging to prevent Alzheimer’s Disease (AMYPAD) The AMYPAD Initiative is a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of β-amyloid PET imaging.
Models of Patient Engagement for Alzheimer's Disease (MOPEAD) The MOPEAD project, is designed to assess different Patient Engagement models across Europe, to identify efficient approaches of earlier identification of mild AD dementia and prodromal AD patients.
EU Research and Innovation Programme
Horizon 2020 Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.